Exom is proud to be awarded as one of the “TOP 30 FASTEST PRIVATE GROWING COMPANIES TO WATCH IN 2021” by the Silicon Review.

On this occasion, Dr. Luigi Visani, President and CEO of Exom Group Srl, Speaks to The Silicon Review: ‘Our Mission is to Stay at the Forefront of Innovating Clinical Trials and Become a Market Leader in Digital Clinical Trials in the CRO Industry’

In the Interview, Dr. Visani elaborates on Exom’s strategy on future development and integration of innovative technologies in clinical trials, to make them more efficient and enabling drugs getting market access faster. All with the goal of improving patients lives all over the world.

Read the interview at the Silicon Review: https://thesiliconreview.com/magazine/profile/exom-group-at-the-forefront/

SiliconReviewAward 2021
Global Health & Pharma Excellence AwardsAward Winner 2022

Exom is proud to announce that Global Health & Pharma has awarded us the 2022 Global Excellence Award as "Most innovative Full-Service CRO - 2022" for our pioneering, cutting-edge use of technology in clinical trials to support study stakeholders.

Share This